Explore Potential Treatments in Obstructive Sleep Apnea and Obesity Clinical Trials
Obstructive Sleep Apnea (OSA) is a serious medical condition that affects not only sleep quality but also cardiovascular and metabolic health. It is a known risk factor for heart disease, diabetes, and other serious conditions, significantly impacting daily life. While current treatments—such as weight loss programs, positive airway pressure (PAP) devices, and surgical options—can be beneficial, they may not be effective or suitable for all patients, leaving a significant unmet need for exploring more effective solutions in the form of clinical trials.
Obstructive sleep apnea (OSA) affects an estimated 30 million adults in the United States, and obesity or overweight is a leading risk factor, with up to 70% of people with OSA being obese.
Prime Revival Research Institute is conducting Sleep Apnea and Obesity Clinical Trials in Texas. The goal is to reduce the frequency of apnea and hypopnea events, improve sleep quality, and alleviate the challenges related to sleep-disorder breathing. This study will evaluate the safety and efficacy of an investigational medication compared to a placebo in adults with moderate-to-severe obstructive sleep apnea and obesity.
You may qualify to participate if you:
- Are 18 years of age or older, male, or female
- Have a clinical diagnosis of moderate-to-severe OSA history
- Have a BMI 27 kg/m2 or more
*Additional criteria may apply.
Your doctor will go over the additional study criteria with you to determine if you qualify. If you qualify and decide to participate in the sleep apnea and obesity clinical trials in Texas, you will receive all study-related care, free of cost.
*You will be compensated for your time and travel expenses.
*If you think you may be eligible to participate in the paid sleep studies or would like more information, please enter your information in the form so our research team can determine if you qualify and could contact you about the study.
About The Sleep Apnea and Obesity Clinical Trials
Prime Revival Research Institute is conducting sleep apnea and obesity clinical trials in Texas to evaluate the safety and efficacy of a study drug in people with obstructive sleep apnea and obesity. Obstructive sleep apnea is especially common in people with obesity or overweight. This clinical trial will test if an investigational medicine can help treat people with obstructive sleep apnea and obesity or overweight.
The investigational medicine being tested in this study may help people with their breathing during sleep. If you decide to take part in the clinical trial, you will be randomly assigned (that is by chance) to get either the investigational medicine or placebo. During the sleep apnea and obesity clinical trials you will attend visits with doctors and researchers in-person at a clinic.
About Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a condition in which the upper airway continuously becomes blocked during sleep, reducing airflow and causing frequent awakenings. OSA commonly co-occurs with obesity, as excess fatty tissue around the neck and abdomen increases airway obstruction. This leads to poor sleep quality, daytime fatigue, and heightened risks of cardiovascular and metabolic issues due to intermittent drops in oxygen levels.
Obesity or overweight is a significant risk factor for OSA, doubling the likelihood of moderate-to-severe cases. Key symptoms include loud snoring, gasping for air during sleep, and persistent daytime sleepiness. While Continuous Positive Airway Pressure (CPAP) is often the first treatment for moderate-to-severe OSA, weight loss interventions are recommended to reduce apnea severity. Innovative clinical studies are now evaluating new therapies that may offer additional support for patients with both moderate-to-severe OSA and obesity, aiming to improve their quality of life and overall health outcomes.
RECRUITINGSTATUS AND CRITERIA
$ 99
Per Month- Age 18 years or older
- Gender Male or female
- Condition Obstructive Sleep Apnea and Obesity
- Location Texas
Get Started: What to Expect?
If you would like to learn more about our sleep apnea and obesity clinical trials, please fill out the form above. A research representative will contact you to provide more information about the study. If you qualify for the sleep apnea and obesity clinical trials, you will be invited to our study site for screening. If you qualify after the screenings and choose to participate, you will be asked to sign an informed consent form outlining the criteria and details of the investigational study treatment.
After signing, you may be asked to answer health-related questions and undergo various assessments and tests to determine your eligibility as a clinical trial participant. During the study, participants will be randomly assigned (that is by chance) to get either the investigational medicine or placebo.
**Participants will receive free-of-cost investigational treatment. If you choose to join our sleep apnea and obesity clinical trials in Texas, you may also receive study-related care from healthcare professionals.
Frequently Asked Questions (FAQs)
What is Obstructive Sleep Apnea (OSA), and how is it related to obesity?
OSA is a sleep disorder where the upper airway becomes partially or completely blocked during sleep, causing breathing interruptions. Obesity or overweight is a significant risk factor for OSA, as excess weight, especially around the neck, can press on the airway and increase the likelihood of airway collapse.
How can OSA and obesity or overweight impact my overall health?
Both OSA and obesity or overweight can lead to serious health problems if untreated, OSA may cause high blood pressure, heart disease, and stroke due to repeated drops in oxygen levels. Combined with obesity, these risks increase further, potentially leading to conditions like Type 2 diabetes, cardiovascular disease, and reduced quality of life.
What are common OSA symptoms for individuals with obesity?
Typical symptoms include loud snoring, gasping, or choking during sleep, excessive daytime sleepiness, morning headaches, and difficulty concentrating. People with obesity or overweight may experience more severe symptoms due to the increased pressure on the airway.
Can weight loss improve symptoms of OSA?
Yes, weight loss can help reduce OSA severity for many people. By decreasing excess tissue around the throat, weight loss can reduce airway obstruction during sleep. However, other treatments like CPAP therapy may still be necessary depending on the individual’s condition.
What is involved in the sleep apnea and obesity clinical trials at Prime Revival Research Institute?
The sleep apnea and obesity clinical trials are designed to evaluate the safety and efficacy of an investigational medication for individuals with obstructive sleep apnea and obesity. As part of the study, participants may undergo health assessments, sleep studies, and regular check-ins to monitor their progress. For those currently using Positive Airway Pressure (PAP) therapy, please note that you will need to discontinue use of the therapy temporarily prior to the sleep study; your study team will explain this requirement in detail. These paid sleep studies aim to provide valuable new insights and potential treatment options for individuals affected by OSA and obesity.